Left ventricular hypertrophy and renin-angiotensin-aldosterone system: AT1-receptor blockers are in the focus

Left ventricular hypertrophy and renin-angiotensin-aldosterone system: AT1-receptor blockers are in the focus

Left ventricular hypertrophy (LVH) is one of the cardio-vascular continuum components, determining the prognosis of patient with essential hypertension (EH). Pathogenesis of LVH has a multifactor character. Important role in development of cardiomyocites hypertrophy, Intracardiac fibrosis, left vent...

Full description

Bibliographic Details
Main Authors: A V Barsukov, D V Glukhovskoy, M S Talantseva, Z V Bagaeva, E V Pronina, M P Zobnina, T S Sveklina, A E Korovin
Format: Article
Language:Russian
Published: IP Morozov P.V. 2013-03-01
Series:Системные гипертензии
Subjects:
essential hypertension
left ventricular hypertrophy
renin-angiotensin-aldosteron system
telmisartan
Online Access:https://syst-hypertension.ru/2075-082X/article/view/28961
id doaj-34c2c468d7c44ffd92f5536e6171170c
record_format Article
spelling doaj-34c2c468d7c44ffd92f5536e6171170c2020-11-25T03:13:11ZrusIP Morozov P.V.Системные гипертензии2075-082X2542-21892013-03-01101889626062Left ventricular hypertrophy and renin-angiotensin-aldosterone system: AT1-receptor blockers are in the focusA V BarsukovD V GlukhovskoyM S TalantsevaZ V BagaevaE V ProninaM P ZobninaT S SveklinaA E KorovinLeft ventricular hypertrophy (LVH) is one of the cardio-vascular continuum components, determining the prognosis of patient with essential hypertension (EH). Pathogenesis of LVH has a multifactor character. Important role in development of cardiomyocites hypertrophy, Intracardiac fibrosis, left ventricle cavity dilation belongs to renin-angiotensin-aldosteron system (RAAS). Pharmacologic blockade of RAAS composes the basis of therapy, directed to LVH regress. Application of Telmisartan is considered high-reasonable approach to treatment of EH-patient with LVH.https://syst-hypertension.ru/2075-082X/article/view/28961essential hypertensionleft ventricular hypertrophyrenin-angiotensin-aldosteron systemtelmisartan
collection DOAJ
language Russian
format Article
sources DOAJ
author A V Barsukov
D V Glukhovskoy
M S Talantseva
Z V Bagaeva
E V Pronina
M P Zobnina
T S Sveklina
A E Korovin
spellingShingle A V Barsukov
D V Glukhovskoy
M S Talantseva
Z V Bagaeva
E V Pronina
M P Zobnina
T S Sveklina
A E Korovin
Left ventricular hypertrophy and renin-angiotensin-aldosterone system: AT1-receptor blockers are in the focus
Системные гипертензии
essential hypertension
left ventricular hypertrophy
renin-angiotensin-aldosteron system
telmisartan
author_facet A V Barsukov
D V Glukhovskoy
M S Talantseva
Z V Bagaeva
E V Pronina
M P Zobnina
T S Sveklina
A E Korovin
author_sort A V Barsukov
title Left ventricular hypertrophy and renin-angiotensin-aldosterone system: AT1-receptor blockers are in the focus
title_short Left ventricular hypertrophy and renin-angiotensin-aldosterone system: AT1-receptor blockers are in the focus
title_full Left ventricular hypertrophy and renin-angiotensin-aldosterone system: AT1-receptor blockers are in the focus
title_fullStr Left ventricular hypertrophy and renin-angiotensin-aldosterone system: AT1-receptor blockers are in the focus
title_full_unstemmed Left ventricular hypertrophy and renin-angiotensin-aldosterone system: AT1-receptor blockers are in the focus
title_sort left ventricular hypertrophy and renin-angiotensin-aldosterone system: at1-receptor blockers are in the focus
publisher IP Morozov P.V.
series Системные гипертензии
issn 2075-082X
2542-2189
publishDate 2013-03-01
description Left ventricular hypertrophy (LVH) is one of the cardio-vascular continuum components, determining the prognosis of patient with essential hypertension (EH). Pathogenesis of LVH has a multifactor character. Important role in development of cardiomyocites hypertrophy, Intracardiac fibrosis, left ventricle cavity dilation belongs to renin-angiotensin-aldosteron system (RAAS). Pharmacologic blockade of RAAS composes the basis of therapy, directed to LVH regress. Application of Telmisartan is considered high-reasonable approach to treatment of EH-patient with LVH.
topic essential hypertension
left ventricular hypertrophy
renin-angiotensin-aldosteron system
telmisartan
url https://syst-hypertension.ru/2075-082X/article/view/28961
work_keys_str_mv AT avbarsukov leftventricularhypertrophyandreninangiotensinaldosteronesystemat1receptorblockersareinthefocus
AT dvglukhovskoy leftventricularhypertrophyandreninangiotensinaldosteronesystemat1receptorblockersareinthefocus
AT mstalantseva leftventricularhypertrophyandreninangiotensinaldosteronesystemat1receptorblockersareinthefocus
AT zvbagaeva leftventricularhypertrophyandreninangiotensinaldosteronesystemat1receptorblockersareinthefocus
AT evpronina leftventricularhypertrophyandreninangiotensinaldosteronesystemat1receptorblockersareinthefocus
AT mpzobnina leftventricularhypertrophyandreninangiotensinaldosteronesystemat1receptorblockersareinthefocus
AT tssveklina leftventricularhypertrophyandreninangiotensinaldosteronesystemat1receptorblockersareinthefocus
AT aekorovin leftventricularhypertrophyandreninangiotensinaldosteronesystemat1receptorblockersareinthefocus
_version_ 1724648211617939456

Similar Items